Search results
Results From The WOW.Com Content Network
Ranbaxy's Malvinder Singh remained as CEO after the transaction. [11] The addition of Ranbaxy Laboratories extended Daiichi-Sankyo's operations, with the combined company worth about US$30 billion. [12] In 2009, it was reported that former Novartis Senior Vice-President Yugal Sikri would lead the Indian operations of Ranbaxy Laboratories. [13] [14]
Shivinder Mohan Singh is an Indian businessman and erstwhile billionaire with Fortis Healthcare, Religare, and Ranbaxy Laboratories. Singh was the non-executive vice chairman of Fortis Healthcare, an Indian company. He is currently under arrest for criminal breach of trust along with his brother Malvinder Mohan Singh. The two have many cases of ...
In 2006, Advent had sold 96.7% of the company to Ranbaxy. Terapia S.A. therefore went through a brand name change, and so it became Terapia Ranbaxy. Two years later, the Japanese pharmaceutical giant Daiichi Sankyo had purchased 1/5 of the company, and so Terapia Ranbaxy became part of the giant.
The fifty rupiah coin (Rp50) is a denomination of the Indonesian rupiah.It was first introduced in 1971 and last minted in 2003. As of 2020, only aluminum Rp50 coins dating from 1999 through 2003 remain legal tender, although it is rarely seen in circulation due to its extremely low value.
Volini is a brand of pain relief medical spray and cream manufactured, marketed and sold by Sun Pharma in India. [1] [2] The product was created by Ranbaxy Laboratories, but has been owned by Sun Pharma ever since Ranbaxy was acquired by the latter in 2014. [3]
The following other wikis use this file: Usage on ar.wikipedia.org رانباكسي; Usage on azb.wikipedia.org رانباکسی لابراتورو
Dapoxetine has been marketed and approved in more than 50 countries. [39] Dapoxetine has been approved in Italy, Spain, Mexico, South Korea, and New Zealand in 2009 and 2010; marketed in Sweden, Austria, Germany, Finland, Spain, Portugal, and Italy. It has also been approved in France, Russia, Malaysia, Philippines, Argentina, and Uruguay. [6]
Avanafil is a PDE5 inhibitor approved for erectile dysfunction by the FDA on April 27, 2012 [2] and by EMA on June 21, 2013. [3] Avanafil is sold under the brand names Stendra and Spedra.